Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
You may also like
Gainers
Latest Crypto News
「Bull Buddy」 is once again hyping up for a long position, with an average entry price of $31.97.
Kalshi has completed a $1 billion funding round at a $1.1 billion valuation
Coinbob has launched an on-chain address monitoring and copying tool for the Pacifica chain, allowing users to synchronize and earn Pacifica token rewards.
OpenMind is pleased to announce a partnership with Circle to build AI-powered payment infrastructure.
Circle announces Foundation, initial phase aims to enhance financial resilience of small businesses in the U.S.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]